Skip to main content
Top
Published in: Digestive Diseases and Sciences 7/2018

01-07-2018 | Publisher Correction

Correction to: Hypervigilance to a Gluten-Free Diet and Decreased Quality of Life in Teenagers and Adults with Celiac Disease

Authors: Randi L. Wolf, Benjamin Lebwohl, Anne R. Lee, Patricia Zybert, Norelle R. Reilly, Jennifer Cadenhead, Chelsea Amengual, Peter H. R. Green

Published in: Digestive Diseases and Sciences | Issue 7/2018

Login to get access

Excerpt

The original version of the article unfortunately contained formatting errors in Table 3. The correct version of Table 3 is given below.
Table 3
Celiac disease specific quality of life (QOL)a and knowledgeb in adults and teenagers by vigilance level
Adults
Extremely vigilant (n = 12)
Less vigilant (n = 38)
Total (n = 50)
t
p
Overall CDQOL
64.2 (16.0)
77.2 (12.2)
74.1 (14.2)
− 3.0
0.004
Subscales
 Dysphoria
85.4 (15.8)
94.1 (8.2)
92.0 (11.0)
− 2.5
0.016
 Limitations
56.7 (18.2)
73.8 (16.3)
69.7 (18.2)
− 3.1
0.004
 Health concerns
65.0 (20.4)
71.1 (19.3)
69.6 (19.5)
− 0.9
0.36
 Inadequate treatment
53.1 (25.1)
74.0 (24.0)
69.0 (25.7)
− 2.6
0.012
Knowledge
5.7 (0.7)
5.1 (0.8)
5.2 (0.8)
2.2
0.035
Teenagers
Extremely vigilant (n = 7)
Less vigilant (n = 23)
Total (n = 30)
t
p
Overall CDOPQOL
74.6 (14.2)
68.8 (15.2)
70.1 (14.9)
0.9
0.38
Subscales
 Social
72.5 (16.7)
69.3 (16.5)
70.0 (16.3)
0.4
0.66
 Uncertainty
66.7 (27.6)
69.9 (16.6)
69.2 (19.2)
− 0.4
0.70
 Isolation
83.9 (7.1)
71.2 (20.1)
74.2 (18.6)
1.6
0.12
 Limitations
75.0 (15.2)
63.4 (26.0)
66.1 (24.2)
1.1
0.27
Knowledge
5.1 (0.7)
4.8 (0.9)
4.9 (0.9)
0.9
0.39
aHigher CD-QOL (adults) or CDPQOL (teenagers) overall scores and subscales suggest higher degree of QOL; Scales 0–100
bHigher knowledge scores suggest higher knowledge; Scale 0–6
Metadata
Title
Correction to: Hypervigilance to a Gluten-Free Diet and Decreased Quality of Life in Teenagers and Adults with Celiac Disease
Authors
Randi L. Wolf
Benjamin Lebwohl
Anne R. Lee
Patricia Zybert
Norelle R. Reilly
Jennifer Cadenhead
Chelsea Amengual
Peter H. R. Green
Publication date
01-07-2018
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 7/2018
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5049-9

Other articles of this Issue 7/2018

Digestive Diseases and Sciences 7/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.